Sian writes about emerging start-up companies and new research from academia. She is especially interested in the pet health space, as well as the introduction of digital technology for both companion animals and livestock. She also has an interest in increasing Animal Pharm's equine coverage, as she owns horses herself.
In addition to covering animal health news and conducting interviews with worldwide companies, Sian also works on the evolving Animal Pharm Product Approvals Index.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Sian Lazell
The US FDA Center for Veterinary Medicine (CVM) released a five-year action plan for supporting antimicrobial stewardship in veterinary settings.
German firm GeneQuine Therapeutics has gained positive efficacy data for the gene therapy approach developed by the firm and Baylor College of Medicine.
UK firm Animalcare has seen its shares slowly begin to recover since the divestment of its wholesale division.
Royal DSM and Novozymes have launched a new feed additive that removes bacterial debris with the aim of improving feed efficiency and digestibility in broiler chickens.
A team from the UK's Pirbright Institute are filing a patent for a newly-developed peste de petit ruminants (PPR) vaccine, which they used as part of a program in India.
Irish veterinary generics specialist Chanelle has opened a new €10 million ($11.6 million) manufacturing facility at its headquarters in Loughrea, Galway.